Executive Director, HTE and Lead Discovery Capabilities, Merck Sharp & Dohme
Global Engage is pleased to announce as part of their Drug Discovery Series of events, The Medicinal Chemistry Summit: USA which will be held on September 17th – 18th 2018 in Boston, USA. This event will be the sister meeting to their successful European Medicinal Chemistry Summit of 2017.
Vice President, Discovery Chemistry & Technologies, & Distinguished Research Fellow, AbbVie
Senior Research Scientist, Early CVRM Medicinal Chemistry, R&D Biopharmaceuticals, AstraZeneca
Designed to attract experts working in all areas of medicinal chemistry, The Summit has three tracks focusing on key topics such as hit-to-lead optimization, protein degradation, DNA encoded libraries, SBDD, small molecule immuno-oncology research, and the use of Artificial Intelligence in the drug discovery process. The Summit will provide a forum to network, learn and engage with senior representatives of leading pharmaceutical and biotech companies worldwide.